Trials / Completed
CompletedNCT05825638
Evolution of Pulsed Oxygen Saturation During Interval Training Compared to Continuous Training in COPD Patients
Evolution of Pulsed Oxygen Saturation Throughout an Interval Training Session Compared to a Continuous Training Session in Patients With Chronic Obstructive Pulmonary Disease With Exercise-induced Oxygen Desaturation.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- Groupe Hospitalier du Havre · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A problem often observed during exercise training is oxygen desaturation exclusively during exercise in some patients. In the case of exercise-induced desaturation, it may be suggested to train these patients in interval training to limit exercise-induced desaturation. Interval training consists of alternating active phases of short duration (often 30 seconds to 1 minute) followed by a short active or passive recovery phase of equivalent duration to the previous phase. Investigators therefore hypothesise that interval training on a cycloergometer or treadmill can limit exercise-induced desaturation in COPD patients. The aim of the study is to observe the evolution of pulsed oxygen saturation between a continuous training session and a interval training session.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Continuous training session | Continuous training consists of a 5 minute warm up, 5 minute cool down and 20 minutes of moderate intensity work. The workload is set at 60% of the patient's maximum power |
| OTHER | Interval training session | Interval training consists of a 5-minute warm-up, a 5-minute cool-down and 20 minutes of alternating 60 seconds of high-intensity work (100% of the maximum power recorded in the incremental test that was carried out when the patient was admitted to the pulmonary rehabilitation department) and 60 seconds of unloaded pedalling or rest. |
Timeline
- Start date
- 2023-01-10
- Primary completion
- 2025-09-30
- Completion
- 2025-10-10
- First posted
- 2023-04-24
- Last updated
- 2026-01-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05825638. Inclusion in this directory is not an endorsement.